参考文献
1: Yeh DY, Yang YC, Wang JJ. Hepatic Warm Ischemia-Reperfusion-Induced Increase in Pulmonary Capillary Filtration Is Ameliorated by Administration of a Multidrug Resistance-Associated Protein 1 Inhibitor and Leukotriene D4 Antagonist (MK-571) Through Reducing Neutrophil Infiltration and Pulmonary Inflammation and Oxidative Stress in Rats. Transplant Proc. 2015 May;47(4):1087-91. doi: 10.1016/j.transproceed.2014.10.061. PubMed PMID: 26036526.
2: Wu NC, Tong SP, Yang YC, Wang JC, Wang JJ. MK-571 attenuates kidney ischemia and reperfusion-induced airway hypersensitivity in rats. Transplant Proc. 2014 May;46(4):1127-30. doi: 10.1016/j.transproceed.2013.12.041. PubMed PMID: 24815144.
3: Takeuchi K, Shibata M, Kashiyama E, Umehara K. Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats. Exp Ther Med. 2012 Sep;4(3):524-532. Epub 2012 Jun 29. PubMed PMID: 23181130; PubMed Central PMCID: PMC3503844.
4: Rahi MM, Heikkinen TM, Hakala KE, Laine KP. The effect of probenecid and MK-571 on the feto-maternal transfer of saquinavir in dually perfused human term placenta. Eur J Pharm Sci. 2009 Jul 12;37(5):588-92. doi: 10.1016/j.ejps.2009.05.005. Epub 2009 May 18. PubMed PMID: 19454316.
5: Wong WS, Zhu H, Liao W. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Eur J Pharmacol. 2007 Dec 1;575(1-3):134-41. Epub 2007 Jul 24. PubMed PMID: 17689528.
6: Blain JF, Sirois P. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571. Prostaglandins Leukot Essent Fatty Acids. 2000 Jun;62(6):361-8. PubMed PMID: 10913229.
7: Gök S, Onal A, Cinar MG, Evinç A. The antinociceptive effect of leukotriene D(4) receptor antagonist, MK-571, in mice: possible involvement of opioidergic mechanism. Eur J Pharmacol. 1999 Dec 15;386(2-3):195-200. PubMed PMID: 10618470.
8: Vellenga E, Tuyt L, Wierenga BJ, Müller M, Dokter W. Interleukin-6 production by activated human monocytic cells is enhanced by MK-571, a specific inhibitor of the multi-drug resistance protein-1. Br J Pharmacol. 1999 May;127(2):441-8. PubMed PMID: 10385244; PubMed Central PMCID: PMC1566046.
9: Gaddy JN, Margolskee DJ, Bush RK, Williams VC, Busse WW. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis. 1992 Aug;146(2):358-63. PubMed PMID: 1489125.
10: Depré M, Margolskee DJ, Van Hecken A, Hsieh JS, Buntinx A, De Schepper PJ, Rogers JD. Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist. Eur J Clin Pharmacol. 1992;43(4):431-3. PubMed PMID: 1451726.
11: Depré M, Margolskee DJ, Hsieh JY, Van Hecken A, Buntinx A, De Lepeleire I, Rogers JD, De Schepper PJ. Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man. Eur J Clin Pharmacol. 1992;43(4):427-30. PubMed PMID: 1451725.
12: Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Gauthier JY, Leger S, Lord A, Masson P, et al. Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571. Can J Physiol Pharmacol. 1991 Dec;69(12):1847-54. PubMed PMID: 1666333.
13: Robinett RS, Hsieh JY. Stereoselective determination of R(-)- and S(+)-MK-571, a leukotriene D4 antagonist, in human plasma by chiral high-performance liquid chromatography. J Chromatogr. 1991 Sep 18;570(1):157-65. PubMed PMID: 1797821.
14: Kips JC, Joos GF, De Lepeleire I, Margolskee DJ, Buntinx A, Pauwels RA, Van der Straeten ME. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):617-21. PubMed PMID: 1892302.
15: Amirav I, Pawlowski N. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med. 1991 May 2;324(18):1288. PubMed PMID: 1849613.
16: McLeod JD, Piper PJ. Effect of ICI 198,615, SK+F 104,353, MK-571 and CGP45715A on cysteinyl leukotriene-induced responses in guinea-pig heart. Prostaglandins. 1991 Apr;41(4):395-406. PubMed PMID: 1871378.
17: Denzlinger C, Grimberg M, Kapp A, Haberl C, Wilmanns W. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat. Br J Pharmacol. 1991 Apr;102(4):865-70. Erratum in: Br J Pharmacol 1991 Jul;103(3):1834. PubMed PMID: 1855116; PubMed Central PMCID: PMC1917974.
18: Rasmussen JB, Margolskee DJ, Eriksson LO, Williams VC, Andersson KE. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571. Ann N Y Acad Sci. 1991;629:436. PubMed PMID: 1952571.
19: Ford-Hutchinson AW. Regulation of the production and action of leukotrienes by MK-571 and MK-886. Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:9-16. PubMed PMID: 1847788.
20: Young RN. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571. Agents Actions Suppl. 1991;34:179-87. Review. PubMed PMID: 1793062.
(last updated: 4/20/2016).
